Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression
- PMID: 23249141
- PMCID: PMC3749710
- DOI: 10.1089/ars.2012.5027
Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression
Abstract
Significance: Alzheimer disease (AD) is an age-related neurodegenerative disease. AD is characterized by progressive cognitive impairment. One of the main histopathological hallmarks of AD brain is the presence of senile plaques (SPs) and another is elevated oxidative stress. The main component of SPs is amyloid beta-peptide (Aβ) that is derived from the proteolytic cleavage of amyloid precursor protein.
Recent advances: Recent studies are consistent with the notion that methionine present at 35 position of Aβ is critical to Aβ-induced oxidative stress and neurotoxicity. Further, we also discuss the signatures of oxidatively modified brain proteins, identified using redox proteomics approaches, during the progression of AD.
Critical issues: The exact relationships of the specifically oxidatively modified proteins in AD pathogenesis require additional investigation.
Future directions: Further studies are needed to address whether the therapies directed toward brain oxidative stress and oxidatively modified key brain proteins might help delay or prevent the progression of AD.
Figures
![FIG. 1.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3749710/bin/fig-1.gif)
![FIG. 2.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3749710/bin/fig-2.gif)
![FIG. 3.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3749710/bin/fig-3.gif)
![FIG. 4.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3749710/bin/fig-4.gif)
![FIG. 5.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3749710/bin/fig-5.gif)
![FIG. 6.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3749710/bin/fig-6.gif)
![FIG. 7.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3749710/bin/fig-7.gif)
![FIG. 8.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3749710/bin/fig-8.gif)
Similar articles
-
Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.Free Radic Res. 2002 Dec;36(12):1307-13. doi: 10.1080/1071576021000049890. Free Radic Res. 2002. PMID: 12607822 Review.
-
Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment.J Bioenerg Biomembr. 2009 Oct;41(5):441-6. doi: 10.1007/s10863-009-9241-7. J Bioenerg Biomembr. 2009. PMID: 19777328 Free PMC article. Review.
-
Redox proteomics and amyloid β-peptide: insights into Alzheimer disease.J Neurochem. 2019 Nov;151(4):459-487. doi: 10.1111/jnc.14589. Epub 2018 Nov 27. J Neurochem. 2019. PMID: 30216447 Free PMC article. Review.
-
Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.Free Radic Biol Med. 2007 Sep 1;43(5):658-77. doi: 10.1016/j.freeradbiomed.2007.05.037. Epub 2007 Jun 13. Free Radic Biol Med. 2007. PMID: 17664130 Free PMC article. Review.
-
Alzheimer's disease.Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Subcell Biochem. 2012. PMID: 23225010 Review.
Cited by
-
Peroxiredoxin 1 inhibits streptozotocin-induced Alzheimer's disease-like pathology in hippocampal neuronal cells via the blocking of Ca2+/Calpain/Cdk5-mediated mitochondrial fragmentation.Sci Rep. 2024 Jul 8;14(1):15642. doi: 10.1038/s41598-024-66256-x. Sci Rep. 2024. PMID: 38977865 Free PMC article.
-
Pyrogallol intermediates elicit beta-amyloid secretion via radical formation and alterations in intracellular trafficking, distinct from pyrogallol-generated superoxide.Redox Biol. 2024 Jul;73:103180. doi: 10.1016/j.redox.2024.103180. Epub 2024 May 24. Redox Biol. 2024. PMID: 38795546 Free PMC article.
-
Phytochemical analysis, antioxidant, acetylcholinesterase, and α-amylase inhibitors from extract.J Tradit Chin Med. 2024 Jun;44(3):496-504. doi: 10.19852/j.cnki.jtcm.2024.03.001. J Tradit Chin Med. 2024. PMID: 38767633 Free PMC article.
-
Pregnenolone derivatives for the treatment of Alzheimer's disease: synthesis, and in vitro inhibition of amyloid β1-42 peptide aggregation, acetylcholinesterase and carbonic anhydrase-II.RSC Adv. 2024 May 7;14(21):14742-14757. doi: 10.1039/d4ra01536c. eCollection 2024 May 2. RSC Adv. 2024. PMID: 38716099 Free PMC article.
-
Characterisation of premature cell senescence in Alzheimer's disease using single nuclear transcriptomics.Acta Neuropathol. 2024 May 2;147(1):78. doi: 10.1007/s00401-024-02727-9. Acta Neuropathol. 2024. PMID: 38695952 Free PMC article.
References
-
- Aaronson RM. Graven KK. Tucci M. McDonald RJ. Farber HW. Non-neuronal enolase is an endothelial hypoxic stress protein. J Biol Chem. 1995;270:27752–27757. - PubMed
-
- Abe T. Tohgi H. Isobe C. Murata T. Sato C. Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer's disease. J Neurosci Res. 2002;70:447–450. - PubMed
-
- Aksenov MY. Tucker HM. Nair P. Aksenova MV. Butterfield DA. Estus S. Markesbery WR. The expression of key oxidative stress-handling genes in different brain regions in Alzheimer's disease. J Mol Neurosci. 1998;11:151–164. - PubMed
-
- Aluise CD. Robinson RAS. Cai JA. Pierce WM. Markesbery WR. Butterfield DA. Redox proteomics analysis of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer's disease: insights into memory loss in MCI. J Alzheimers Dis. 2011;23:257–269. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical